Biologics Drug Development-3 day course

Drug development of various types of biologic products is a complex and multidisciplinary process. The development integrates knowledge of the underlying disease, target identification, principles on biologics safety, planning strategy for toxicology and clinical studies incorporating the key aspects of manufacturing and controls. This three-day course provides insights into all parts that should be addressed to effectively develop new biologics, from discovery to product launch.
The course will also be offered as an online course. Those who choose to attend online will have access to all streamed lectures for 1 month. The course is organized in cooperation with SwedenBIO.

If you prefer to register to the same course but visit on on-site at Läkemedelsakademin please visit
https://www.lakemedelsakademin.se/produkt/biologics-drug-development-3-day-course-5/?preview=1

Who should attend?

The course is aimed for those involved in drug development of biologics (eg in small and medium-sized companies), and need a comprehensive picture of the complex development chain. During the course you will get insight on how to work in the different stages of development, what to think about and what pitfalls there are on the road. To get the most exchange of the course, it is an advantage to have a natural science background.

Preliminary program

Preliminary program

Program Committée

Olga Björklund, BioInvent, Tuulikki Lindmark, TuuLife Science, Frida Lawenius, SwedenBio and Lisa Bandholtz, Apotekarsocieteten